US2018251446A1PendingUtilityA1

Novel Carboxylic Acid Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1

Assignee: LILLY CO ELIPriority: Oct 29, 2014Filed: May 8, 2018Published: Sep 6, 2018
Est. expiryOct 29, 2034(~8.3 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 25/04A61P 29/00A61P 19/02C07C 235/40C07D 401/12C07D 401/04C07C 2601/14C07D 211/62A61K 31/445A61K 31/4725C07C 2601/08
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides compounds of Formula 1, or a pharmaceutically acceptable salts, thereof, where R, X, A, E, and G are as described herein, methods of preparing the compounds, and use of the compounds to treat pain and/or inflammation.

Claims

exact text as granted — not AI-modified
1 - 29 . (canceled) 
     
     
         30 . A method of treating a patient in need of treatment for pain or inflammation associated with arthritis or osteoarthritis said method comprising administering to the patient an effective amount of 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof, in combination with an effective amount of a second agent selected from the group consisting of ibuprofen, aspirin, acetaminophen, celecoxib, naproxen, and ketoprofen.

Join the waitlist — get patent alerts

Track US2018251446A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.